The DEA says the Schedule III registration-form question asking cannabis businesses to admit to dealing in controlled substances without DEA authorization is designed ‘to support a complete and fair evaluation of each application,’ and ‘the broader registration process is designed to evaluate applicants based on their current ability to operate within the federal framework.’